Crime & Law · India
Bombay High Court Admonishes FDA Over Cadila Drug Ban
The Bombay High Court has criticized the Maharashtra Food and Drug Administration (FDA) for its actions regarding the sale of Cadila drugs. The court described the FDA's approach as using "a sword to kill a mosquito," urging the body to exercise its power with restraint and judiciously. The FDA had banned the sale of certain Cadila drugs, a decision that Cadila has challenged. The court warned of imposing heavy costs on the FDA.
How outlets across the spectrum covered it
L 2 C 2 R 0
- Left (2): The Hindu, The Telegraph (India)
- Centre (2): Deccan Herald, The Economic Times